Adma Biologics (ADMA) Property, Plant & Equipment (Net) (2011 - 2026)
Powered by 
Analysis
Adma Biologics (ADMA) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Adma Biologics | 2.18 Bn | 2.05 Bn | 86.28 Mn | 66.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.66 Mn |
| Mar 31, 2026 | 65.01 Mn |
| Dec 31, 2025 | 65.06 Mn |
| Sep 30, 2025 | 69.51 Mn |
| Jun 30, 2025 | 57.50 Mn |
| Mar 31, 2025 | 57.71 Mn |
| Dec 31, 2024 | 54.71 Mn |
| Sep 30, 2024 | 53.69 Mn |
| Jun 30, 2024 | 54.33 Mn |
| Mar 31, 2024 | 55.32 Mn |
| Dec 31, 2023 | 53.84 Mn |
| Sep 30, 2023 | 54.81 Mn |
| Jun 30, 2023 | 56.31 Mn |
| Mar 31, 2023 | 57.37 Mn |
| Dec 31, 2022 | 58.26 Mn |
| Sep 30, 2022 | 56.95 Mn |
| Jun 30, 2022 | 54.95 Mn |
| Mar 31, 2022 | 53.22 Mn |
| Dec 31, 2021 | 50.94 Mn |
| Sep 30, 2021 | 48.39 Mn |